Inflammatory factors such as IL-17, IFN-γ, TNF-α and IL-6, and chemokines MIP-1a and CXCL9 in CSF and plasma, can serve as potential markers for MS, indicating the important role of neuroinflammation in MS [129–131]. This evidence concerns the gene IFNG and myeloid sarcoma.